" class="no-js "lang="en-US"> Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer - Medtech Alert
Saturday, February 24, 2024

Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer

Kineticos Life Sciences announced today that Thomas A. Pitler, Ph.D. has joined as President and Chief Operating Officer.  Dr. Pitler joins Kineticos Life Sciences with 20+ years of experience as a senior executive in the biopharmaceutical industry. Dr. Pitler brings extensive experience in pharmaceutical research, clinical development, market analysis, business development, financing, and M&A transactions.

Kineticos Life Sciences is a life sciences consulting firm that represents centers of excellence in cell & gene therapy and oncology, combined with a vast depth of expertise in driving strategy and growth for companies in these areas. With experience in hundreds of projects with biotechs, contract service companies, and investors, among others, we have built an incredible team of consultants, operating experts, and a network of KOLs, who bring unprecedented experience to the passionate, seamless collaborations we build with our clients.  In this new role with Kineticos Life Sciences, Dr. Pitler’s responsibilities will include long-term strategy, management of operations, and client interactions.

Prior to joining Kineticos Life Sciences, Dr. Pitler ran an independent consulting practice, and prior to that was employed by Heron Therapeutics, VetMed Therapeutics, Capture Pharmaceuticals, Chimerix, Neurogen Corporation, and the University of Maryland School of Medicine.

When asked about his new role at Kineticos Life Sciences, Dr. Pitler said, “I am delighted to join the Kineticos Life Sciences team. We get to work with world-class companies every day and help in the development and commercialization of truly exciting and novel technologies.  I look forward to working with the team at Kineticos Life Sciences to help companies succeed in their mission and ultimately improve medical treatments and human health.”

Shailesh Maingi, Founder and Chairman of Kineticos Life Sciences, noted: “Tom has great experience working with a wide range of biopharmaceutical companies in scientific, management, and business development roles.  His scientific background, business acumen, and deep knowledge of the industry will greatly aid in the service of our clients and in maintaining the highest quality of advisory services.”

Kineticos Ventures’, the Venture Capital group within Kineticos, CEO Frank Lis adds “We are excited to have Tom as part of the Kineticos team. His experience and knowledge of the biotech industry will be integral as Kineticos Life Sciences looks to grow and invest in this space.”

Kineticos Life Sciences is excited to bring Dr. Pitler on as the President and Chief Operating Officer of Kineticos Life Sciences. With this new addition, Kineticos Life Sciences continues to strengthen its position as an industry leader in the Life Sciences.

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more